rs8046121
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_000246.4(CIITA):c.520G>A(p.Gly174Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00256 in 1,614,124 control chromosomes in the GnomAD database, including 95 homozygotes. In-silico tool predicts a benign outcome for this variant. 5/6 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.014 ( 52 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 43 hom. )
Consequence
CIITA
NM_000246.4 missense
NM_000246.4 missense
Scores
5
Clinical Significance
Conservation
PhyloP100: 2.71
Genes affected
CIITA (HGNC:7067): (class II major histocompatibility complex transactivator) This gene encodes a protein with an acidic transcriptional activation domain, 4 LRRs (leucine-rich repeats) and a GTP binding domain. The protein is located in the nucleus and acts as a positive regulator of class II major histocompatibility complex gene transcription, and is referred to as the "master control factor" for the expression of these genes. The protein also binds GTP and uses GTP binding to facilitate its own transport into the nucleus. Once in the nucleus it does not bind DNA but rather uses an intrinsic acetyltransferase (AT) activity to act in a coactivator-like fashion. Mutations in this gene have been associated with bare lymphocyte syndrome type II (also known as hereditary MHC class II deficiency or HLA class II-deficient combined immunodeficiency), increased susceptibility to rheumatoid arthritis, multiple sclerosis, and possibly myocardial infarction. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0063800514).
BP6
Variant 16-10902076-G-A is Benign according to our data. Variant chr16-10902076-G-A is described in ClinVar as [Benign]. Clinvar id is 459198.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0138 (2105/152284) while in subpopulation AFR AF= 0.0472 (1962/41566). AF 95% confidence interval is 0.0455. There are 52 homozygotes in gnomad4. There are 993 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 52 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIITA | NM_000246.4 | c.520G>A | p.Gly174Arg | missense_variant | 7/20 | ENST00000324288.14 | NP_000237.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIITA | ENST00000324288.14 | c.520G>A | p.Gly174Arg | missense_variant | 7/20 | 1 | NM_000246.4 | ENSP00000316328.8 |
Frequencies
GnomAD3 genomes AF: 0.0138 AC: 2102AN: 152166Hom.: 52 Cov.: 32
GnomAD3 genomes
AF:
AC:
2102
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00138 AC: 2021AN: 1461840Hom.: 43 Cov.: 35 AF XY: 0.00116 AC XY: 843AN XY: 727214
GnomAD4 exome
AF:
AC:
2021
AN:
1461840
Hom.:
Cov.:
35
AF XY:
AC XY:
843
AN XY:
727214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0138 AC: 2105AN: 152284Hom.: 52 Cov.: 32 AF XY: 0.0133 AC XY: 993AN XY: 74464
GnomAD4 genome
AF:
AC:
2105
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
993
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
MHC class II deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_noAF
Benign
CADD
Benign
LIST_S2
Benign
T;T;T;T;T
MetaRNN
Benign
T;T;T;T;T
Sift4G
Benign
.;T;T;T;T
Vest4
0.45, 0.65, 0.47
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at